Ticker Details
Neuronetics, Inc. Common Stock
IPO Date:	June 25, 2018
Sector:	Healthcare
Industry:	Diagnostics and Research
Market Cap:	$83.51M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.24 | 3.90%
Avg Daily Range (30 D):	$0.08 | 4.64%
Avg Daily Range (90 D):	$0.08 | 4.96%

Institutional Daily Volume
Avg Daily Volume:	.49M
Avg Daily Volume (30 D):	2.51M
Avg Daily Volume (90 D):	2.29M

Trade Size
Avg Trade Size (Sh.):	178
Avg Trade Size (Sh.) (30 D):	342
Avg Trade Size (Sh.) (90 D):	269

Institutional Trades
Total Institutional Trades:	155
Avg Institutional Trade:	$1.89M
Avg Institutional Trade (30 D):	$.58M
Avg Institutional Trade (90 D):	$.58M
Avg Institutional Trade Volume:	.18M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$4.49M
Avg Closing Trade (30 D):	$.58M
Avg Closing Trade (90 D):	$.58M
Avg Closing Volume:	487.75K

News

Apr 10, 2026 @ 6:27 PM Deal Dispatch: Unilever Buys Grüns, Pershing Sq... Source: Caroline Ryan

Oct 31, 2025 @ 8:30 PM Neuronetics Reports Inducement Grant Under Nasdaq ... Source: Neuronetics, Inc.

Dec 10, 2024 @ 3:00 PM Neuronetics and Greenbrook TMS Announce Closing of... Source: N/A

Jul 2, 2024 @ 2:40 PM Neuronetics (STIM) Expands NeuroStar Portfolio Wit... Source: Zacks Equity Research

Jul 1, 2024 @ 12:02 PM NeuroStar® Launches Better Me Provider Program ... Source: Neuronetics

Financials
	TTM	Q1 2026	Q3 2025
Basic EPS		$-.16	$-.13
Diluted EPS		$-.16	$-.13
Revenue		$34.45M	$37.3M
Gross Profit		$16.15M	$17.11M
Net Income / Loss		$-10.78M	$-9.4M
Operating Income / Loss		$-9M	$-7.32M
Cost of Revenue		$18.3M	$20.19M
Net Cash Flow	$-37.34M	$-15.17M	$17M
PE Ratio